Randomized phase 2b dose-escalation trial of stem cell therapy with laromestrocel for aging frailty.

Frailty, a syndrome that decreases healthspan in older individuals, lacks effective therapies. We conducted a randomized, dose-finding clinical trial to test whether human bone marrow-derived allogeneic mesenchymal stem cells (MSCs; laromestrocel) improve physical functioning and …

46 Early
Design 5
Sample 7
Peer Review 18
Replication 6
Transparency 10

Transforming tumor microenvironments: nanotechnology and gene therapy in cellular signaling and epigenetic insight into chemo-resistance.

Chemoresistance remains the primary cause of cancer treatment failure, yet current understanding remains fragmented across isolated mechanistic studies. This review provides a unified framework linking tumor microenvironment (TME) signaling, epigenetic reprogramming, and nanotherapeutic intervention as …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Delayed forebrain excitatory and inhibitory neurogenesis in STRADA-related megalencephaly via mTOR hyperactivity.

Biallelic pathogenic variants in STRADA (STE20-related adaptor alpha), an upstream regulator of the mechanistic target of rapamycin (mTOR) pathway, result in megalencephaly, drug-resistant epilepsy, and severe intellectual disability. This study explores how mTOR pathway hyperactivity …

46 Early
Design 5
Sample 7
Peer Review 18
Replication 6
Transparency 10

Mesenchymal stromal/stem cells in tumour initiation, progression and therapy.

The expanding study of mesenchymal stromal/stem cells (MSC) in cancer has amounted to a growing understanding of their underlying biology in malignant and non-malignant settings. In addition to supporting homeostasis in nearly all normal tissues, …

46 Early
Design 5
Sample 7
Peer Review 18
Replication 6
Transparency 10

From complexity to clarity: aging bone marrow niche in bone and blood regeneration and malignancy.

The bone marrow niche (BMN) plays a central role in regulating hematopoietic stem-cell (HSC) maintenance, lineage commitment, and immune homeostasis, while also supporting osteogenesis and maintaining skeletal integrity. Once considered static, the BMN is now …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Skin aging: mechanisms, evaluation, and rejuvenation.

Skin aging, the most visible and accessible manifestation of organismal aging, reflects systemic physiological decline, compromising barrier integrity, immune defense, and regenerative capacity-functions essential for overall tissue homeostasis and longevity. Understanding why and how the …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

How aging immune systems damage lungs—and what treatments might help

If your immune system ages slower, your lungs might stay healthier longer—but we need better treatments to prove it works.

This review examines how immunosenescence (age-related immune decline) drives lung diseases like COPD, fibrosis, and cancer, and surveys emerging treatments including senolytics, stem cell therapy, and lifestyle interventions. While it synthesizes current knowledge well, it's …

36 Early
Design 4
Sample 2
Peer Review 13
Replication 7
Transparency 10

Targeting therapy-induced senescence across multiple breast cancer subtypes in a metastatic bone-like microenvironment

Chemotherapeutic treatment of breast cancer with Doxorubicin (DOX) can induce tumor and stromal cell senescence leading to therapy-resistance. Senescence-associated secretory phenotype (SASP) promotes secretion of pro-inflammatory and tumorigenic factors causing systemic inflammation. Combined, this can …

34 Early
Design 5
Sample 7
Peer Review 4
Replication 6
Transparency 12

A Dual Approach to Glioblastoma Treatment with Epigenetic Reprogramming and Neurogenetic Modulation.

Glioblastoma is a highly aggressive primary brain tumour marked by extensive genomic and epigenomic alterations, cellular heterogeneity, and therapeutic resistance. Despite maximal surgical resection followed by chemoradiotherapy, median survival remains approximately 15 months, reflecting the …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Can we reverse aging by partially reprogramming cells?

This review examines 'partial reprogramming'—a technique that temporarily activates rejuvenation factors to reverse aging hallmarks in cells and tissues without turning them into cancer-prone stem cells. Early evidence suggests it can restore tissue function and …

36 Early
Design 4
Sample 2
Peer Review 13
Replication 7
Transparency 10

Remote control for genes: Using electromagnetic fields to turn aging genes on and off

New tool lets scientists turn aging genes on and off from outside the body, offering a way to test anti-aging therapies that weren't possible before.

Scientists developed a technology that uses electromagnetic fields to remotely activate specific genes in living mice with precise timing and location control. They tested it by partially reversing aging processes, modeling Alzheimer's disease, and treating …

48 Early
Design 6
Sample 8
Peer Review 19
Replication 5
Transparency 10

New hydrogel with stem cell vesicles reverses aging damage in bone healing

Researchers created a gel that helps aging bones heal better by reducing inflammation and protecting stem cells from aging damage.

Researchers created a gel containing special vesicles from stem cells that reduces inflammation and cellular aging in aging bone, significantly improving bone and tendon healing in an osteoporosis model. This demonstrates a novel 'senomorphic' approach—directly …

42 Early
Design 6
Sample 6
Peer Review 16
Replication 5
Transparency 9

Blood as a window and tool for reversing aging: what recent research reveals

Blood might reveal how fast you're aging and could be used to treat aging itself—but human evidence is still early.

This review examines how blood composition—proteins, metabolites, and cell fragments—both reflects aging and actively drives it across the body. Young blood transferred to older animals reverses some aging markers, suggesting blood-based therapies could become anti-aging …

40 Early
Design 4
Sample 2
Peer Review 14
Replication 10
Transparency 10

How Planarians Lose Fertility with Age—and How to Reverse It

Researchers discovered that aging planarians (regenerative flatworms) lose fertility not because their stem cells fail, but because their body's positional 'blueprint' gradually shifts out of alignment. By manipulating the molecular signals that control body polarity, …

39 Early
Design 6
Sample 5
Peer Review 14
Replication 5
Transparency 9

Combined and Layered Fat Injection for Lower Eyelid Wrinkles: Comparative Efficacy in Mild and Severe Cases.

BACKGROUND: Lower eyelid wrinkles pose a persistent challenge in facial rejuvenation. Layered autologous fat grafting using Coleman fat, SVF-gel, and nanofat offers a regenerative approach with potential synergistic benefits. OBJECTIVE: To assess the efficacy and …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Why Aging Cells Sometimes Help—and Sometimes Hurt—Muscle Repair

Understanding how aging cells block muscle repair could lead to new treatments to help older adults stay strong and independent.

This review examines cellular senescence (aging cells that stop dividing) in muscle regeneration, finding that senescent cells play a dual role: they can briefly help repair muscle after injury, but when they accumulate in aging …

37 Early
Design 4
Sample 2
Peer Review 15
Replication 7
Transparency 9

Rethinking senescent cells: When to stop them, when to keep them

Some aging cells help your body work properly; new strategies could clear harmful ones while keeping helpful ones.

This review challenges the assumption that senescent cells are always harmful, showing that some actually support healthy aging through wound healing and tissue maintenance. The authors propose a new strategy: prevent bad senescence while selectively …

37 Early
Design 4
Sample 2
Peer Review 13
Replication 9
Transparency 9

Elastin production by mRNA technology for rejuvenation of aged skin.

Elastin is a crucial component of elastic fibers, conferring mechanical elasticity and flexibility while facilitating cell interactions within skin tissue, thereby orchestrating the organized structure and damage repair of the extracellular matrix (ECM). Although elastin …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Circadian disruption and cellular senescence: emerging perspectives in periodontitis.

Periodontitis is a chronic inflammatory disease characterized by progressive destruction of periodontal tissues and alveolar bone, traditionally attributed to microbial dysbiosis. Emerging evidence suggests that host-intrinsic factors, including circadian rhythm disruption (CRD) and cellular senescence, …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology.

Radiotherapy-induced skin fibrosis is a chronic progressive complication of radiotherapy that impairs function, aesthetics, and quality of life yet remains under-recognized and undertreated. While acute cutaneous toxicities are typically transient, chronic sequelae such as fibrosis, …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10